InsidersTradesSigma
Follow the 金河生物 share price and the full insider trade history of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 金河生物 has recorded 3 public disclosures. Market capitalisation: €3.7bn. The latest transaction was reported on 19 August 2025 (Sale). Among the most active insiders: 内蒙古金河控股有限公司. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
金河生物是一家在XSHE市场上市的健康和制药公司。它专注于生物产品的开发和生产。